Educational

GLP-1 receptor agonists — semaglutide, liraglutide, tirzepatide and the rest — do several things at once, and one of them reshapes eating in a way the prescribing conversation often skips past.

They slow gastric emptying. Food sits in the stomach longer, fullness arrives sooner and lasts longer, and meals that used to be routine can become uncomfortable. That single mechanism drives most of the practical food questions people end up asking.

What the drugs actually do

GLP-1 is a hormone your gut releases when you eat. These medications mimic it, and the effects stack: insulin release increases when glucose is high, glucagon release drops, the stomach empties more slowly, and appetite signalling in the brain shifts.

That last effect is the one people describe most vividly — the reduction in what's commonly called food noise, the background chatter about what to eat next. Tirzepatide adds a second receptor target, GIP, which appears to make it more potent on both weight and glucose.

None of this changes what a food's glycemic load is. It changes how much of that food arrives at once, and how much of it you want.

Protein stops being optional

This is the most important practical point, and it gets less attention than it should.

When total intake drops sharply, some of the weight lost is lean tissue. Across the major trials, a meaningful share of weight lost on these medications is fat-free mass — the estimates vary by study and method, and the range commonly cited runs from roughly a quarter to nearly 40%. Some lean loss is normal with any weight loss. The concern is that with appetite this suppressed, protein intake can fall well below what's needed to limit it.

So the priority order on a smaller plate inverts. Protein first, then vegetables, then whatever carbohydrate still fits. A common target is somewhere around 1.0 to 1.5 g of protein per kilogram of body weight, which is difficult to hit on 1,200 calories without deliberately planning for it.

Resistance training does the other half of that job. The combination of adequate protein and lifting is what preserves muscle; neither alone does it as well.

The foods that cause trouble

Nausea is the most common side effect, and it's fairly predictable in what triggers it.

• Large meals. The stomach is emptying slowly; volume is the main problem. Smaller and more frequent works better.
• High-fat and fried food. Fat already slows emptying, and this stacks on top of it.
• Alcohol. Many people report much lower tolerance, and the reduced desire for it is a commonly reported side effect in its own right.
• Very sweet food. Frequently reported as unpleasant in a way it wasn't before.
• Eating quickly. The fullness signal arrives late; eating slowly avoids overshooting it.

Constipation is the other common complaint, and it responds to the usual things: fibre, fluid, and movement. Fibre needs to come up gradually, since a sudden increase on a slowed gut makes matters worse.

Where glycemic load still matters

It would be easy to conclude that food composition stops mattering once the medication is doing the work. Two reasons it still does.

First, portions are small, so nutrient density per bite is at a premium. A plate that's half refined carbohydrate at 1,300 calories a day leaves very little room for protein, fibre, and micronutrients.

Second, these medications are frequently prescribed alongside metformin, insulin, or a sulfonylurea. The glucose-lowering stacks, and a high-GL meal followed by a correction dose is exactly the setup that produces a low a few hours later — made harder to predict by the fact that the food itself is arriving slower than usual.

Insulin timing gets genuinely harder

If you take rapid-acting insulin with meals, delayed gastric emptying is a real complication. The standard pre-bolus timing assumes food starts arriving in 15 to 20 minutes. On a GLP-1, it may not.

That mismatch produces a low first and a rise later — the insulin peaking before the carbohydrate does. Dosing adjustments here are a conversation with your prescriber, and a CGM makes the pattern visible in a way finger sticks won't.

What happens if you stop

Worth knowing before starting, because it shapes how you use the time on the medication.

In the extension of the STEP 1 trial, participants regained roughly two-thirds of the weight they'd lost within a year of stopping, and cardiometabolic markers moved back toward baseline with it. These are treatments for a chronic condition rather than a course of something.

The implication is practical: the period of suppressed appetite is the easiest window you'll ever get to build eating habits that don't depend on the drug. Protein at every meal, vegetables by default, and a portion size you've practised are all considerably easier to establish now than later.

What to raise with your care team

Dose adjustments for insulin or sulfonylureas as intake falls. Whether your protein target is being met. Whether nausea is manageable or a reason to change the titration schedule. Any history of gastroparesis or pancreatitis. And what the plan is if you stop.

None of that is something to work out from an article — including this one. What an article can do is tell you which questions are worth the appointment.

Worth booking that conversation early rather than at the point where something has already gone wrong. The first weeks on a dose increase are when most of these issues surface, and that's a predictable enough window to plan around.